InvestorsObserver
×
News Home

What is Wall Street's Target Price for Forma Therapeutics Holdings Inc (FMTX) Stock Thursday?

Thursday, September 29, 2022 01:42 PM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Forma Therapeutics Holdings Inc (FMTX) Stock Thursday?

InvestorsObserver is giving Forma Therapeutics Holdings Inc (FMTX) an Analyst Rating Rank of 16, meaning FMTX is ranked higher by analysts than 16% of stocks. The average price target for FMTX is $20.75 and analyst’s rate the stock as a Buy.

Overall Score - 3.4
Wall Street analysts are rating FMTX a Buy today. Find out what this means to you and get the rest of the rankings on FMTX!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers. InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Forma Therapeutics Holdings Inc Stock Today?

Forma Therapeutics Holdings Inc (FMTX) stock has risen 0.1% while the S&P 500 has fallen -2.28% as of 1:41 PM on Thursday, Sep 29. FMTX is up $0.02 from the previous closing price of $19.94 on volume of 354,538 shares. Over the past year the S&P 500 has fallen -16.64% while FMTX has fallen -10.05%. FMTX lost -$4.00 per share the over the last 12 months. Click Here to get the full Stock Report for Forma Therapeutics Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App